Industry News
Opinion: Australian science all “R” and no “D”
Duncan Jones, Executive Director of Science Industry Australia, argues we need to take the “development” part of the R&D equation more seriously if Australia is to benefit from our investment in research. [ + ]
Nominations open for 2011 Victoria Prize
The $50,000 Victoria Prize and six $18,000 Victoria Fellowships are open for nomination, with applications closing 3 August. [ + ]
Greens table petition supporting medical research
Over 12,000 signatures adorn a petition in support of continued health and medical research spending that will be tabled in parliament tomorrow by The Greens. [ + ]
PR: Inventors to receive better trans-Tasman patent process
Australian and New Zealand inventors will receive a more streamlined trans-Tasman patent process.
[ + ]Inventors to receive better trans-Tasman patent process
Australian and New Zealand inventors will receive a more streamlined trans-Tasman patent process.
[ + ]Bioniche to acquire Plasvaac Holdings
Bioniche, is set to acquire Plasvaac in order to strengthen its animal health portfolio with Plasvaac’s serum-derived plasma products. [ + ]
Coral genome projected completed
Australian scientists have used next generation sequencing to produce the first full genome of the ubiquitous Great Barrier Reef coral, Acropora millepora. [ + ]
IXC Australia closes doors
Industry collaboration organisation IXC Australia has ceased trading, citing the loss of a major contract and soft economic conditions. [ + ]
DNA timber fingerprinting may assist fight against illegal logging
Advances in DNA 'fingerprinting' and other genetic techniques are making it harder for illegal loggers to get away with destroying protected rainforests.
[ + ]UniQuest brokers international biofuel partnership
The University of Queensland and Clemson University in the US will collaborate on research and development on a range of biofuel technologies. [ + ]
BIO 2011 report: Australian biotechnology trials and tribulations
The last 12 months has been one of tremendous ups and downs for Australian biotechnology companies. [ + ]
Collaboration contributes to understanding toxicity of the new E. coli strain
HPA researchers, using Thermo Scientific's mass spectrometry technology, have been able to identify the protein toxins expressed by the deadly strain of E. coli in Europe.
[ + ]BIO 2011 report: Australian biotechnology spotlight
ALS surveys some of the big movers and shakers in the Australian biotechnology industry from the year that’s past and the year ahead. [ + ]
Starpharma brings its novel technology to leading cancer treatment
Starpharma (ASX:SPL) is conducting pre-clinical studies on popular chemotherapy treatment, docaetaxel, reformulated using the company’s dendrimer technology. [ + ]
BIO 2011: Kim Carr on the importance of biotechnology
Senator Kim Carr, Minister for Innovation, Industry, Science and Research, says biotechnology is central to Labor’s agenda. [ + ]
